Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Blue Sky Uranium Expands Drill Plan to Advance the Ivana Uranium-Vanadium Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sona Nanotech Inc
C.SONA
Alternate Symbol(s):
SNANF
Healthcare
Biotechnology
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company is developing targeted hyperthermia, a photothermal cancer therapy, which uses therapeutic heat to treat solid cancer tumors. It is engaged in the development of pre-clinical nanomedical therapy for the treatment of cancer using its proprietary and...
biocompatible gold nanorods (GNR) leveraging on its core manufacturing technology for these biocompatible GNRs, scientific experience, accumulated study data and laboratory. It has developed multiple proprietary methods for the manufacture of gold nanoparticles which it uses for the development of both cancer therapies and diagnostic testing platforms. Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:SONA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(82)
•••
Zenderflask
X
Post by
Zenderflask
on Jan 28, 2025 7:27pm
Proactive Investor Interview - Communications
(240)
•••
beenthere
X
Comment by
beenthere
on Jan 17, 2025 12:07pm
RE:Wasn't this a $3+ stock before??? Nope, not going to touch
Sorry about your $3 comment couldn't be further from the truth! Could look it up but I will leave that to you! I sold at $12 and was far away from the top when I did.
(82)
•••
Zenderflask
X
Post by
Zenderflask
on Jan 13, 2025 10:23am
Sona Letter to Investors
Letter sent to Sona investors. Reflections on 2024 and Looking Ahead To 2025
(82)
•••
Zenderflask
X
Post by
Zenderflask
on Jan 13, 2025 10:16am
Sona has now Been Peer Reviewed and Published
Positive achievement with the recent publishing. Sona Nanotech's THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-Reviewed Scientific Journal
(82)
•••
Zenderflask
X
Post by
Zenderflask
on Jan 10, 2025 1:08pm
Grammer Lesson
Three question marks? Three exclamation marks? Someone didn't pass their english class is what it looks like. You might want to review this site to get a more updated view of what has been taking
...more
(456)
•••
therookie87
X
Post by
therookie87
on Jan 10, 2025 11:20am
Wasn't this a $3+ stock before??? Nope, not going to touch
this one at all!!!
(82)
•••
Zenderflask
X
Post by
Zenderflask
on Jan 10, 2025 11:11am
Peer Review and Publication
I see that Sona has a peer review on thecancer therapy about to be published. Frontiers of Oncology and Immunotherapy provide an avenue of promotion for these publications as well I believe that the
...more
(864)
•••
Pandora
X
Post by
Pandora
on Oct 18, 2024 8:49pm
Patent Issued Oct, 15, 2024
I started this patent trail so I guess I should finish it. It is a patent for manufacturing Metal Nanoparticles, gold in particular, I believe. I would copy & paste a portion of the Abstract and
...more
(864)
•••
Pandora
X
Post by
Pandora
on Oct 03, 2024 9:46pm
Patent Approved - Ready for Issue
16/761,473 | 3277.006: Metal Nanoparticles and Methods of Making Same This patent application is now considered approved and will be issued on Oct. 15/24. The new Patent Number is 12117447
(864)
•••
Pandora
X
Post by
Pandora
on Sep 25, 2024 3:06pm
Concussion and Football!
Brett Favre has initiated a lot of talk recently about concussions in Football on the heels of his being diagnosed with Parkinson's Disease. I see they also have new padded covers for football
...more
(864)
•••
Pandora
X
Comment by
Pandora
on Sep 09, 2024 9:06pm
RE:Patent Still Moving!
The good news is that the Patent is being considered for a "Notice of Allowance" and thence an "Issue Date as Approved". The bad news is that an error(s) has been detected and the
...more
(864)
•••
Pandora
X
Post by
Pandora
on Jul 19, 2024 6:39pm
Patent Still Moving!
The following patent has been designated as ready for issue. i.e. it is approved and will be given an issue date in the near future: 16/761,473 | 3277.006: Metal Nanoparticles and Methods of
...more
(864)
•••
Pandora
X
Comment by
Pandora
on Jul 09, 2024 8:36pm
RE:RE:Successfull!!!
It looks like things are positive in the Patent process. SONA has a patent application going through the USPTO that has been granted "Notice of Allowance and Fees Due" today. They were
...more
(864)
•••
Pandora
X
Post by
Pandora
on May 21, 2024 7:34pm
New Press Release
SONA moving in to the big leagues i.e. they have hired a Chief Medical Officer to oversee and guide the Company as they carry the Company into the throes of FDA and HC approval adventures. Sona
...more
(0)
•••
mrlee113
X
Comment by
mrlee113
on May 13, 2024 4:40pm
RE:Successfull!!!
I thought the latest result was pretty positive, but it's been dropping since...did I miss something?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
How Web3 Will Fundamentally Reshape Finance
Largest integrated facility services provider in Canada releases financial results for Q1, 2025
Healthcare and Clinical Stage Drug Development Company Acquires NoBrainer Imaging Centers
This company is set to benefit from a change in Ontario legislation